PLAQUENIL ( DrugBank: - )

4 diseases

告示番号	疾患名（ページ内リンク）	臨床試験数
46	悪性関節リウマチ	6
49	全身性エリテマトーデス	1
53	シェーグレン症候群	6
96	クローン病	1

46. 悪性関節リウマチ

臨床試験数 : 4,356 / 薬物数 : 2,567 - (DrugBank : 415) / 標的遺伝子数 : 192 - 標的パスウェイ数 : 228

diseases per page:

Showing 1 to 6 of 6 diseases

Filter by

No.	TrialID	Date_ enrollment	Date_ registration	Public_title	Scientific_title	Condition	Intervention	Primary_ sponsor	Secondary_ sponsor	Recruitment_ Status	Inclusion_ gender	Target_ size	Phase	Countries
1	EUCTR2014-005418-45-SE (EUCTR)	04/05/2015	18/03/2015	Are risk factors factors of pertaining to or involving the heart and blood vessels and markers chara ...	Improved cardiovascular risk factors and inflammatory markers in Rheumatoid Arthritis and Systemic L ...	Rheumatoid Arthritis and Systemic Lupus Erythematosus;Therapeutic area: Diseases [C] - Immune System ...	Trade Name: Plaquenil INN or Proposed INN: HYDROXYCHLOROQUINE	Christine Bengtsson	Solveig Wållberg-Jonsson	Not Recruiting	Female: yes Male: yes		Phase 2	Sweden
2	EUCTR2011-004720-35-NO (EUCTR)	04/05/2015	26/01/2015	A multicenter, randomized, open-label, blinded-assessor, phase 4 study in patients with early rheuma ...	A multicenter, randomized, open-label, blinded-assessor, phase 4 study in patients with early rheuma ...	Rheumatoid arthritis (RA) MedDRA version: 18.0;Level: PT;Classification code 10039073;Term: Rheumato ...	Trade Name: Cimzia INN or Proposed INN: CERTOLIZUMAB PEGOL Trade Name: Orencia INN or Proposed INN: ABA ...	Karolinska Institutet	NULL	Authorised-recruitment may be ongoing or finished	Female: yes Male: yes	800	Phase 4	Finland;Denmark;Norway;Sweden
3	EUCTR2013-003658-26-NL (EUCTR)	13/11/2013	18/10/2013	Individualised treatment strategy based on disease activity for early RA patients in usual clinical ...	Treat-to-target strategy for early RA patients in usual clinical practice: The COBRA Cohort Study - ...	Early Active Rheumatoid Arthritis;Therapeutic area: Diseases [C] - Immune System Diseases [C20]	Trade Name: Methotrexate Product Name: Methotrexate INN or Proposed INN: Methotrexate Other descriptive ...	VU University Medical Center	NULL	Not Recruiting	Female: yes Male: yes	120	Human pharmacology (Phase 1): no Therapeutic exploratory (Phase 2): no Therapeutic confirmatory - (P ...	Netherlands
4	EUCTR2012-005275-14-NO (EUCTR)	19/03/2013	04/02/2013	Remission in rheumatoid arthritis – assessing withdrawal of disease-modifying antirheumatic drugs	Remission in rheumatoid arthritis – assessing withdrawal of disease-modifying antirheumatic drugs in ...	Rheumatoid arthritis (RA) MedDRA version: 15.1;Level: PT;Classification code 10039073;Term: Rheumato ...	Trade Name: Methotrexate Pfizer 2,5 mg tabletter Trade Name: Methotrexate Pfizer 2,5 mg tabletter Trad ...	Diakonhjemmet Hospital AS	NULL	Not Recruiting	Female: yes Male: yes	360	Phase 4	Norway
5	EUCTR2006-001428-38-GB (EUCTR)	18/09/2006	29/09/2006	Remission Induction in Very Early Rheumatoid Arthritis (RIVERA):a comparison of etanercept plus meth ...	Remission Induction in Very Early Rheumatoid Arthritis (RIVERA):a comparison of etanercept plus meth ...	Patients with early inflamatory arthritis (duration of symptoms of < 12 weeks) who are at very high ...	Trade Name: Enbrel Trade Name: Methorexate Trade Name: Depo-Medrone Trade Name: Salazopyrin En-Tabs Trad ...	University Hospitals Birmingham NHS Foundation Trust	NULL	Not Recruiting	Female: yes Male: yes	20	Phase 4	United Kingdom
6	EUCTR2004-002006-30-GB (EUCTR)	17/11/2004	17/02/2005	Triple therapy in early active rheumatoid arthritis - TEAR	Triple therapy in early active rheumatoid arthritis - TEAR	Rheumatoid arthritis	Product Name: Methotrexate INN or Proposed INN: Methotrexate Trade Name: Salazopyrin En-Tabs Product Na ...	North Glasgow NHS Trust	NULL	Not Recruiting	Female: yes Male: yes	96		United Kingdom

First Previous1Next Last

先頭へ

49. 全身性エリテマトーデス

臨床試験数 : 993 / 薬物数 : 702 - (DrugBank : 184) / 標的遺伝子数 : 116 - 標的パスウェイ数 : 200

diseases per page:

Showing 1 to 1 of 1 diseases

Filter by

No.	TrialID	Date_ enrollment	Date_ registration	Public_title	Scientific_title	Condition	Intervention	Primary_ sponsor	Secondary_ sponsor	Recruitment_ Status	Inclusion_ agemin	Inclusion_ agemax	Inclusion_ gender	Target_ size	Phase	Countries
1	EUCTR2014-005418-45-SE (EUCTR)	04/05/2015	18/03/2015	Are risk factors factors of pertaining to or involving the heart and blood vessels and markers chara ...	Improved cardiovascular risk factors and inflammatory markers in Rheumatoid Arthritis and Systemic L ...	Rheumatoid Arthritis and Systemic Lupus Erythematosus;Therapeutic area: Diseases [C] - Immune System ...	Trade Name: Plaquenil INN or Proposed INN: HYDROXYCHLOROQUINE	Christine Bengtsson	Solveig Wållberg-Jonsson	Not Recruiting			Female: yes Male: yes		Phase 2	Sweden

First Previous1Next Last

53. シェーグレン症候群

臨床試験数 : 305 / 薬物数 : 325 - (DrugBank : 104) / 標的遺伝子数 : 58 - 標的パスウェイ数 : 188

diseases per page:

Showing 1 to 6 of 6 diseases

Filter by

No.	TrialID	Date_ enrollment	Date_ registration	Public_title	Scientific_title	Condition	Intervention	Primary_ sponsor	Secondary_ sponsor	Recruitment_ Status	Inclusion_ gender	Target_ size	Phase	Countries
1	EUCTR2019-002470-32-NL (EUCTR)	12/12/2022	23/07/2021	NEw Clinical End-points in patients with primary Sjögren’s Syndrome (pSS): an Interventional Trial b ...	NEw Clinical End-points in patients with primary Sjögren’s Syndrome (pSS): an Interventional Trial b ...	Primary Sjögren’s syndrome (pSS) MedDRA version: 21.0;Level: PT;Classification code 10040767;Term: S ...	Trade Name: PLAQUENIL Product Name: Hydroxychloroquine INN or Proposed INN: Hydroxychloroquine Other de ...	ASSISTANCE PUBLIQUE - HOPITAUX DE PARIS ( AP-HP)	NULL	Authorised-recruitment may be ongoing or finished	Female: yes Male: yes	300	Phase 2	Netherlands;Italy
2	EUCTR2019-002470-32-NO (EUCTR)	14/12/2021	26/08/2021	NEw Clinical End-points in patients with primary Sjögren’s Syndrome (pSS): an Interventional Trial b ...	NEw Clinical End-points in patients with primary Sjögren’s Syndrome (pSS): an Interventional Trial b ...	Primary Sjögren’s syndrome (pSS) MedDRA version: 21.0;Level: PT;Classification code 10040767;Term: S ...	Trade Name: PLAQUENIL Product Name: Hydroxychloroquine INN or Proposed INN: Hydroxychloroquine Other de ...	ASSISTANCE PUBLIQUE - HOPITAUX DE PARIS ( AP-HP)	NULL	Authorised-recruitment may be ongoing or finished	Female: yes Male: yes	300	Phase 2	Netherlands;Norway;Italy
3	EUCTR2019-002470-32-IT (EUCTR)	05/10/2021	27/01/2022	Nuovi end-points clinici in pazienti con sindrome di Sjögren primaria (pSS): uno studio interventist ...	NEw Clinical End-points in patients with primary Sjögren's Syndrome (pSS): an Interventional Trial b ...	Primary Sjögren's syndrome (pSS) MedDRA version: 21.0;Level: PT;Classification code 10040767;Term: S ...	Trade Name: Arava Product Name: Leflunomide Product Code: [Leflunomide] INN or Proposed INN: LEFLUNOMID ...	ASSITANCE PUBLIQUE DES HOPITAUX DE PARIS	NULL	Authorised-recruitment may be ongoing or finished	Female: yes Male: yes	300	Phase 2	France;Greece;Spain;Norway;Netherlands;United Kingdom;Italy;Sweden
4	EUCTR2020-001933-11-NL (EUCTR)	10/06/2021	04/06/2021	Leflunomide and Hydroxychloroquine combination therapy for primary Sjögren’s Syndrome	Leflunomide and Hydroxychloroquine combination therapy for primary Sjögren’s Syndrome - RepurpSS-II ...	Primary Sjogren Syndrome;Therapeutic area: Diseases [C] - Immune System Diseases [C20]	Trade Name: Leflunomide Product Name: Leflunomide Trade Name: Plaquenil Product Name: Hydroxychloroquin ...	University Medical Center Utrecht	NULL	Authorised-recruitment may be ongoing or finished	Female: yes Male: yes	52	Phase 2	Netherlands
5	EUCTR2014-003140-12-NL (EUCTR)	21/09/2015	26/08/2015	Leflunomide and Hydroxychloroquine combination therapy for primary Sjogren's Syndrome	Optimizing DMARD-therapy for primary Sjogren's Syndrome - Leflunomide and Hydroxychloroquine combina ...	Sjogren's Syndrome MedDRA version: 18.0;Level: LLT;Classification code 10040766;Term: Sjogren's dise ...	Trade Name: Leflunomide Mylan Product Name: Leflunomide mylan INN or Proposed INN: LEFLUNOMIDE Trade Na ...	UMC Utrecht	NULL	Authorised-recruitment may be ongoing or finished	Female: yes Male: no			Netherlands
6	EUCTR2007-005218-38-FR (EUCTR)	31/01/2008	20/11/2007	Essai prospectif Randomisé contre placebo en double aveugle de l’hydroxychloroQUine dans le traiteme ...	Essai prospectif Randomisé contre placebo en double aveugle de l’hydroxychloroQUine dans le traiteme ...	Syndrome de Sjögren primitif MedDRA version: 8.1;Level: PT;Classification code 10042846;Term: Syndro ...	Trade Name: Plaquenil Product Name: Plaquenil INN or Proposed INN: Sulfate d'hydroxychloroquine	ASSISTANCE PUBLIQUE - HOPITAUX DE PARIS (AP-HP)	NULL	Authorised-recruitment may be ongoing or finished	Female: yes Male: yes			France

First Previous1Next Last

先頭へ

96. クローン病

臨床試験数 : 2,442 / 薬物数 : 1,278 - (DrugBank : 248) / 標的遺伝子数 : 142 - 標的パスウェイ数 : 209

diseases per page:

Showing 1 to 1 of 1 diseases

Filter by

No.	TrialID	Date_ enrollment	Date_ registration	Public_title	Scientific_title	Condition	Intervention	Primary_ sponsor	Secondary_ sponsor	Recruitment_ Status	Inclusion_ agemin	Inclusion_ agemax	Inclusion_ gender	Target_ size	Phase	Countries
1	EUCTR2008-001137-99-GB (EUCTR)	28/04/2009	27/11/2008	CHANGE TO: A PILOT RANDOMISED STUDY TO COMPARE COMBINATION ANTIBIOTIC THERAPY (CIPROFLOXACIN AND DOX ...	CHANGE TO: A PILOT RANDOMISED STUDY TO COMPARE COMBINATION ANTIBIOTIC THERAPY (CIPROFLOXACIN AND DOX ...	Crohn's Disease MedDRA version: 14.1;Level: PT;Classification code 10011401;Term: Crohn's disease;Sy ...	Product Name: Ciprofloxacin Product Code: PL 20532/0012 INN or Proposed INN: Ciprofloxacin hydrochlori ...	Royal Liverpool & Broadgreen University Hospitals Trust	University of Liverpool	Not Recruiting			Female: yes Male: yes	100	Human pharmacology (Phase 1): no Therapeutic exploratory (Phase 2): yes Therapeutic confirmatory - ( ...	United Kingdom

First Previous1Next Last

先頭へ